MediSpend Acquires Alucio to Enhance Scientific Engagement Solutions

MediSpend, a global leader in compliance and stakeholder engagement solutions for the life sciences industry, has completed the acquisition of Alucio, an innovative technology company renowned for its AI-enabled content management and HCP engagement platform, BEACON. This move marks MediSpend's third acquisition in the past year and aims to bolster its ability to facilitate more effective scientific exchanges between life sciences companies and healthcare providers. Alucio's BEACON platform enables seamless and compliant content engagement across medical affairs, clinical affairs, and market access.

The integration of BEACON into the MediSpend platform will expand its functionality to personalize interactions, streamline content distribution, and generate real-time insights, thereby supporting high-impact, compliant scientific exchange on a global scale. This strategic acquisition is aligned with MediSpend's mission to empower life sciences companies to grow their business compliantly while delivering more meaningful stakeholder interactions and insights. By combining MediSpend's compliance infrastructure with Alucio's AI-driven communication capabilities, clients are expected to benefit from a cohesive solution that supports compliant, efficient, and insight-driven engagement across both commercial and medical teams.

The acquisition is set to strengthen MediSpend's position as a leader in life sciences technology, offering next-generation solutions for enhancing how medical affairs teams communicate and engage with HCPs in a compliant manner. With headquarters in Portsmouth, N.H., and offices in Minnesota, New York, Pennsylvania, and the Netherlands, MediSpend provides best-in-class commercial compliance solutions for pharmaceutical, medical device, dental companies, and emerging biotech companies worldwide. Alucio, dedicated to developing innovative software applications for the life sciences industry, is known for its flagship product, Beacon, a modern, AI-enabled scientific exchange platform designed to enhance scientific dialogue and engagement between life science companies and healthcare professionals.